Mar 23, 2026 07:00AM
Nov 6, 2025 07:04AM
Nov 6, 2025 07:04AM
Oct 15, 2025 07:00AM
Oct 15, 2025 07:00AM
Sep 25, 2025 07:00AM
Sep 19, 2025 04:39PM Algernon Announces Preferred Share Class Approved at Annual and Special Meeting
Jun 30, 2025 05:29PM
May 22, 2025 08:50PM
May 13, 2025 07:00AM
Aug 2, 2024 07:00AM
Jul 31, 2024 07:00AM
Jul 16, 2024 08:00AM
May 21, 2024 07:00AM Algernon Pharmaceuticals Engages ICP Securities Inc. for Automated Market Making Services
Apr 24, 2024 07:47AM
Apr 11, 2024 07:00AM
Mar 27, 2024 12:04PM
Dec 27, 2023 07:00AM
Dec 12, 2023 07:42PM
Nov 22, 2023 07:00AM
Jul 14, 2023 06:00PM Algernon Pharmaceuticals Announces Private Placement and Issuance of Shares in Connection with Financial Advisory Agreement
Jun 27, 2023 07:00AM
Apr 20, 2023 07:00AM
Mar 21, 2023 07:00AM
Jan 11, 2023 07:00AM
Jan 9, 2023 07:00AM
Feb 23, 2022 07:00AM
Nov 24, 2021 07:00AM Algernon Pharmaceuticals Announces Positive Feedback from U.S. FDA for Phase 1 Ifenprodil Small Cell Lung Cancer Study
Nov 1, 2021 03:25PM
Aug 11, 2021 07:00AM
Aug 9, 2021 07:00AM
Mar 5, 2021 07:31PM
Dec 30, 2020 08:00AM
Apr 20, 2020 07:45AM
Feb 21, 2020 06:00AM Algernon Pharmaceuticals Announces Increase and Closing of CDN$1.55M Private Placement
Feb 13, 2020 09:00AM

1,155,357 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All